Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2007-8-16
pubmed:abstractText
Combination therapy of irinotecan, leucovorin (LV), and 5-fluorouracil (5-FU)(FOLFIRI regimen) has certain effect on advanced colorectal cancer. However, data of this regimen as first-line chemotherapy for Chinese patients with advanced colorectal cancer is still lacking, and its efficacy and safety still needs to be defined. This study was to explore the efficacy of FOLFIRI regimen as first-line chemotherapy on advanced colorectal cancer in Chinese patients, and observe its safety.
pubmed:language
chi
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1000-467X
pubmed:author
pubmed:issnType
Print
pubmed:volume
26
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
905-8
pubmed:meshHeading
pubmed-meshheading:17697557-Adenocarcinoma, pubmed-meshheading:17697557-Adult, pubmed-meshheading:17697557-Aged, pubmed-meshheading:17697557-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:17697557-Camptothecin, pubmed-meshheading:17697557-Colonic Neoplasms, pubmed-meshheading:17697557-Diarrhea, pubmed-meshheading:17697557-Female, pubmed-meshheading:17697557-Fluorouracil, pubmed-meshheading:17697557-Humans, pubmed-meshheading:17697557-Leucovorin, pubmed-meshheading:17697557-Liver Neoplasms, pubmed-meshheading:17697557-Lymphatic Metastasis, pubmed-meshheading:17697557-Male, pubmed-meshheading:17697557-Middle Aged, pubmed-meshheading:17697557-Nausea, pubmed-meshheading:17697557-Neoplasm Staging, pubmed-meshheading:17697557-Neutropenia, pubmed-meshheading:17697557-Rectal Neoplasms, pubmed-meshheading:17697557-Remission Induction, pubmed-meshheading:17697557-Retrospective Studies, pubmed-meshheading:17697557-Survival Rate, pubmed-meshheading:17697557-Young Adult
pubmed:year
2007
pubmed:articleTitle
[Efficacy of CPT-11 combined 5-FU/CF (FOLFIRI) regimen on advanced colorectal cancer].
pubmed:affiliation
State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, PR China.
pubmed:publicationType
Journal Article, English Abstract